From cerebral hemisheres and from the brainstem of
Chick embrios in vitro // Adv. Biosci. — 1993. — Vol. 87.
— P. 341 – 42.
Albrecht E., Hingel S., Crailsheim K. et al. // Neurobiology
Of Aging. — 1992. — Vol. 13 (Suppl. 1). — P. 127.
Alvarez X. A., Lombardi V. R., Corzo L. et al. Oral Cerebrolysin
Enhances brain alpha activity and improves cognitive
Performance in elderly control subjects // J. Neural.
Transm. — 2000. — Suppl. 59. — Р . 315 – 28.
Alvarez X. A., Lombardi V. R., Fernandez-Novoa L. et al.
Cerebrolysin reduces microglial activation in vivo and i n
Vitro : a potential mechanism of neuroprotection // J. Neural.
Transm. — 2000. — Suppl. 59. — Р . 281 – 92.
Alvarez X. A., Sampedro C., Perez P., et al. Cerebrolysin
Improves brain bioelectrical activity pettern and cognitive
Functioning in traumatic brain injury and in senile dementia
// Int. J. Neuropharm. — 2002. — N 5, Suppl 1. — P.
S92.
Bae C. Y., Cho C. Y., Cho K. et al. A doudleblind, placebocontrolled,
Multicenter study of Cerebrolysin in Alzheimers
Disease // J. Am. Geriatr. Soc. — 2000. — Vol. 48. — par P. 1566 – 571.
Balenty E., Grasmugg B. Erste Ergebnisse der Anwendung
Von Cerebrolysin an Patienten mit Morbus Parkinson
// Neuropsychiatrie. — 1987. — N 1/2 . — Р . 94 – 7.
Baskys A., Wojtowicz J. M. Effects of brain tissue hydrolysate
on synaptic transmission in the hippocampus //
Pharmacol. Biochem. Behav. — 1994. — Vol. 49, N 4. — par Р . 1105 – 107.
Becher B., Blain M., Giacomini P. S., Antel J. P. Inhibition
Of This polarization by soluble TNF rec е ptor is dependent
Omen antigen-presenting cell-derived IL-12 // J. Immunol.
— 1999. — N 162. — Р . 684 – 88.
Becher B., Giacomini P. S., Pelletier D. et al. Interferongamma
Secretion by peripheral blood T-cell subsets in
Multiple sclerosis: correlation with disease phase and interferon-
Beta therapy // Ann. Neurol. — 1999. — N 45. — par Р . 347 – 50.
Biesenbach G., Grafinger P. Cerebrolysin in treatment of
Painful diabetic neuropathy // Wien. Med. Wochenschr. — par 1997. — Vol. 147, N 3. — Р . 63 – 6.
Boado R. J. Brain-derived peptides increase bloodbrain
|
|
|
Barrier GLUT1 glucose transporter gene expression
Via mRNA stabilization // Neurosci. Lett. — 1998. — par N 255(3). — Р . 147 – 50.
Boado R. J. Brain-derived peptides increase the expression
Of a blood-brain barrier GLUT1 glucose transporter reporter
Gene // Neurosci. Lett. — 1996. — N 220 (1). — Р . 53 – 6.
Boado R. J. Brain-derived peptides regulate the steady
State levels and increase stability of the blood-brain
НУu1095 чНu1067 ЫЕОu1041 БЗu1054 ОРu1067 Ы
Тu1054 ОМ7/2009/4 Оu1041 БЗu1054 ОРu1067 Ы Пu1054 О Кu1051 ЛИu1053 НИu1063 ЧЕu1057 СКu1054 ОЙФu1040 АРu1052 МАu1050 КОu1051 ЛОu1043 ГИu1048 И ИЛu1045 ЕКu1040 АРu1057 СТu1042 ВЕu1053 ННu1054 ОЙТu1045 ЕРu1040 АПu1048 ИИ 71
Barrier GLUT1 glucose transporter mRNA // Neurosci.
Lett. — 1995. — N 197(3). — Р . 179 – 82.
Boado R. J. Molecular regulation of the blood-brain barier
GLUT 1 glucose transporter by brain-derived factor, ageing
And dementia // J. Neural. Transm. — 1998. — Vol. 53
(Suppl. ). — P. 98 – 03.
Boado R. J., Wu D., Windisch M. In vivo upregulation of the
Blood-brain barrier GLUT1 glucose transporter by brainderived
Peptides // Neurosci. Res. — 1999. — N 34 (4). — par Р . 217 – 24.
Boehme K. Verstrken Hirnhydrolysate die Wirkung
Trizyklischer Antidepressiva? // Munch. Med. Wochenschr.
— 1975. — Vol. 117, N 40. — Р . 1611 – 612.
Bongioanni P., Mosti S., Moscato G. et al. Decreases in
T-cell tumor necrosis factor alfa binding with interferon
Beta treatment in patients with multiple sclerosis // Arch.
Neurol. — 1999. — N 56. — Р . 71 – 8.
Cerebrolysin. Unterach. Austria. EBEWE Pharmaceuticals. — par 1992. — 22 р .
Cerebrolysin for the treatment of dementia, stroke and
Brain injuries. Unterach. Austria. EBEWE Pharmaceuticals.
|
|
|
— 1995. — 31 р .
Chen S. J. Preliminary report of trial with Cerebrolysin on
Modification of mental retardation after obtaining complete
Seizure freedeom in infantile spasms // Epilepsia. — par 1995. — N 36 (3). — Р . 74 – 5.
Chrysis D., Martensson K., Savendahl L. Interleukin-1beta
And TNF-alpha act in synergy to inhibit longitudinal growth
In fetal rat metatarsal bones // J. Bone Miner. Res. — par 2004 — N 19 (11) — Р . 1805 – 812.
Cruz R., Francis L., Diaz-Suarez C. M., Gonzalez-Fraguela
M. E. Short-term effects of septo-hippocampal pathway
Transsection and cerebrolysin effects on glutathione-related
Enzymes in the rat brain // Rev. Neurol. — 1998. — N 26
(152). — Р . 551 – 54.
Davidson J. R. T. Pharmacotherapy of generalized anxiety
Disorder // J. Clin. Psychiatry. — 2001. — N 62 (suppl.
Р . 46 – 0.
Diener H. Therapie und Verlauf neurologische Erkzankungen.
Stuttgart, Berlin. — 1993. — Р . 237 – 44.
233. Diemath H. E. Therapeutische Ma ß nahmen beim akuten
Sch ä dl-Hirn Trauma // Forum f ü r medizinische Fortbildung:
Neuhofen. — 1992. — Р . 27 – 0.
Domzal T., Zaleska B. Cerebrolizyna w leczeniu niedokrwiennych
Udarow mozgowych // Neur. Neurochir. Pol. — par 1995. — Р . 29 (3). — Р . 325 – 31.
Duma S., Mutz N. Wirksamkeit einer Peptid-Dextran-kombination
(Ceredex) in der Behan dlung von Sch ä del-Hirn-Verletzten
// Neuropsychiatr. — 1990. — N 4/2. — Р . 69 – 2.
Дата добавления: 2018-09-22; просмотров: 140; Мы поможем в написании вашей работы! |
Мы поможем в написании ваших работ!